Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Shafi, D. Hughes, A. Mehta, R. Baker, M. Lipman (London, United Kingdom). Novel assessment of alpha galactosidase A enzyme (GLA) activity in induced sputum (IS) and blood in patients with Anderson Fabry disease (AFD). Eur Respir J 2010; 36: Suppl. 54, 4303

Member's Comments

No comment yet.

Related content which might interest you: Immune and inflammatory responses in induced sputum (IS) in Anderson Fabry disease (AFD), COPD and healthy volunteers Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Serum surfactant protein D (SPD) and response to the combined therapy in patients (pts) with stable COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Correlation of induced sputum (IS) particles size distribution (PDS) and pulmonary function test (PFT) in asthmatics patients (A-pts) Source: Eur Respir J 2004; 24: Suppl. 48, 604s Year: 2004 Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease Year: 2003 Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Erythropoietin (EPO) inhibits the immunohistochemical expression of lysyl oxidase (LOX) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Investigating change in the COPD assessment test (CAT) within α-1 antitrypsin deficiency (A1ATD) Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Levels of alkaline phosphatase (ALP), albumin (ALB) and D dimer (DD) in bronchoalveolar lavage (BAL) in patients with Interstitial lung disease (ILD) Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002 Aα360: A measure of disease and treatment efficacy in alpha-1-antitrypsin (A1AT) deficiency Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Are we missing asthma COPD overlap (ACO) diagnosis among patient with COPD?Alameeri Amel(1), Dudina Alexandra(1) , Stephen Lane(1), Kennedy Merian(2) Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Airstacking (AS): feasibility and effect on peak cough flow (PCF) in patients with neuromusular disease (NMD) Source: Eur Respir J 2003; 22: Suppl. 45, 243s Year: 2003 Repeat polymorphisms (pol.) in the NOS-1 gene and its association with the clinical severity of cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Association between alpha1 antitrypsin (AAT) circulating polymers (CP) and lung and liver disease in patients with AAT deficiency (AATD). Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 Induced sputum (IS) angiogenic cytokines in patients with sarcoidosis (SA) Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Safety of sputum induction (SI) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 Higher plasma total homocysteine (tHcy) level and abnormal methionine loading test (MLT) in family members of patients with pulmonary embolism (PE) and carriers of factor V Leiden (FVL) Source: Annual Congress 2004 - Pulmonary embolism Year: 2004 COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with community acquired pneumonia (CAP) during the treatment program Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 Pulmonary tuberculosis (PT) in patients taking the TNF-a inhibitor inflixinab (INF) Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020